2011 - ISBTS 2011 Symposium


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

Oral Communications 13: Biomarkers

15.246 - Analysis of draining leukocytes from the abdominal fluid to monitor immune events after intestinal transplant. Follow up report

Presenter: Dominik, Meier, Buenos Aires, Argentina
Authors: Dominik Meier1, Agustina Zambernardi1, Carolina Rumbo1, Rodrigo Pappa-Gobi2, Ignacio Pérez-Fernández1, Fernando Chirdo2, Guillermo Docena2, Gabriel Gondolesi1, Martín Rumbo2

246
Analysis of draining leukocytes from the abdominal fluid to monitor immune events after intestinal transplant. Follow up report

Dominik Meier1, Agustina Zambernardi1, Carolina Rumbo1, Rodrigo Pappa-Gobi2, Ignacio Pérez-Fernández1, Fernando Chirdo2, Guillermo Docena2, Gabriel Gondolesi1, Martín Rumbo2

1Instituto de Trasplante Multiorganico - Programa de Inmunobiología e Investigación Traslacional en Trasplante, Hospital Universitario - Fundación Favaloro, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina; 2Laboratorio de Investigaciones del Sistema Inmune, Facultad de Ciencias Exactas Universidad Nacional de La Plata, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Introduction: During intestinal transplant (ITx) operation, intestinal lymphatics are not reconstituted. In our first report, we described the factibility to identify cellular population and donor or recipient origin in the abdominal draining fluid post-ITx. The aim of the present study was to correlate variations of draining cells with post transplant clinical events.

Methods: Fourteen consecutive ITx patients were included in the study (11 pediatric, 3 adult; 10 isolated, 2 liver/intestine, 2 multivisceral). Cell composition of the abdominal draining fluid was analyzed periodically during the first 15 post-ITx days by flow cytometry. To exclude blood contamination, only samples having less than 10,000 erythrocytes/ uL were processed. The correlation between cell parameters (FSC-SSC pattern, CD4/ CD8 ratio, CD69 expression on T cells, increased number of NK/ NKT cells) and clinical events was analyzed. Patients were divided into four study groups according with the presence of post transplant complications as follow: Group 1: No-complications (n=3); Group 2: Diarrhea or increased ostomy output (n=4); Group 3: Extra intestinal infections (n=4); Group 4: Others (pancreatitis, intrabdominal hematoma) (n=3).

Results: Group 1: Cellular pattern varied along the post-ITx period from a mixed leukocyte pattern to an exclusively lymphocytic pattern with predominance of CD4+ T cells (30-60%) by day 5 onwards. Different clinical events showed consistent patterns of cellularity. Group 2: Although the shift to a lymphocytic pattern was observed, a clear appearance of granulocytes and monocytes was detected at the time of the clinical complication. Group 3: Postoperative bacterial infections (3/4) had an increase in the draining granulocytes concomitantly or before the diagnosis of the clinical event. In the setting of viral infections (1/4) draining cells had a dominant increase in monocytes over granulocytes. Group 4: This group presented similar changes than group 2. In most cases with inflammatory adverse events concomitant increase in proportion of CD69+ T cells, decrease of CD4/CD8 ratio and increase of NK/ NKT cells was observed.

Conclusions: Our results indicate that cell analysis of the draining fluid from ITx recipients might be useful as a tool to predict or to support clinical management. This follow up study support the utility of this method to gain insight into intestinal transplant immunobiology.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada